Información del artículo
Abstract
Microorganism involvement in cancer has been known for over a century, and different types of parasites, bacteria and viruses have been associated with oncogenic processes. Among the bacteria, the first recognised was Helicobacter pylori which causes gastric cancer and might be related to extra-gastric cancer in humans. Helicobacter hepaticus has been associated with liver cancers using animal models. Other bacteria such as, Chlamydia psitacii, Borrelia burgdorferi and Streptococcus bovis have been associated with ocular, skin and colorectal cancers, respectively. Also, a commensal bacterium in the human intestine, Bacteroides fragilis, has been linked, very recently, with colorectal cancer using animal models.
Keywords:
Cancer
Microorganisms
Humans
Resumen
La implicación de los microorganismos en el cáncer humano se conoce desde hace más de un siglo y diferentes tipos de parásitos, bacterias y virus se han relacionado con procesos oncogénicos. Dentro de las bacterias, la primera reconocida como carcinogénica fue Helicobacter pylori, que causa cáncer gástrico y podría estar relacionada con cánceres extragástricos en el hombre. Helicobacter hepaticus se ha relacionado con cánceres hepáticos utilizando modelos animales. Otras bacterias, como Chlamydia psitacii, Borrelia burgdorferi y Streptococcus bovis, se han relacionado con cánceres oculares, de piel y colorrectal, respectivamente. Además, una bacteria comensal del intestino humano, Bacteroides fragilis, se ha vinculado muy recientemente con el cáncer colorrectal utilizando modelos animales.
Palabras clave:
Cáncer
Microorganismos
Hombre
El Texto completo está disponible en PDF
References
[1.]
L. Dalton-Griffin, P. Kellam.
Infectious causes of cancer and their detection.
J Biol, 8 (2009), pp. 67
[2.]
C. De Martel, S. Franceschi.
Infections and cancer: established associations and new hypotheses.
Crit Rev Oncol Hematol, 70 (2009), pp. 183-194
[3.]
J.L. Ziegler, F.M. Buonaguro.
Infectious agents and human malignancies.
Frontiers Biosci, 14 (2009), pp. 3455-3464
[4.]
H. Zur Hausen.
Infections causing human cancer.
Whiley-VCH Verlag GmbH & Co, (2006),
[5.]
H. Zur Hausen.
The search for infectious causes of human cancers: where and why (Nobel lecture).
Angew Chem Int Ed Engl, 48 (2009), pp. 5798-5808
[6.]
M. Askanazy.
Über infektion des Menschen mit Distomum felineum (sibiricum) in Ostpreussen und ihren Zusammenhang mit Leberkrebs.
Cent Bakt Orig, 28 (1900), pp. 491-502
[7.]
C. Goebel.
Über die bie Bilharziakrankheit vorkommenden Blasentumoren mit besonderer Berücksichtigung des Carcinoms.
Zeitschr Krebsforsch, 3 (1905), pp. 369-513
[8.]
W.S. Bailey.
Parasites and cancer: sarcoma in dogs associated with Spirocerca lupi.
Ann N Y Acad Sci, 108 (1963), pp. 890-923
[9.]
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.
Lyon, 7–14 June Schistosomes, liver flukes and Helicobacter pylori.
IARC Monogr Eval Carcinog Risks Hum, 61 (1994), pp. 1-241
[10.]
J. M’Faydan, F. Hobday.
Note on the experimental transmission of warts in the dog.
J Comp Pathol Ther, 11 (1898), pp. 341-344
[11.]
P. Rous.
A sarcoma of the fowl transmissible by an agent separable from the tumour cells.
J Exp Med, 13 (1911), pp. 397-411
[12.]
J.J. Bittner.
Some possible effects of nursing on the mammary gland tumor incidence in mice.
Science, 84 (1936), pp. 162
[13.]
S.E. Stewart.
Polyoma virus carcinogenesis.
Acta Unio Int Contra Cancrum, 19 (1963), pp. 255-262
[14.]
C. Friend.
Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia.
J Exp Med, 105 (1957), pp. 307-318
[15.]
B.E. Eddy, G.E. Grubbs, R.D. Young.
Tumor immunity in hamsters infected with adenovirus type 12 or simian virus.
Proc Soc Exp Biol Med, 117 (1964), pp. 575-579
[16.]
A.J. Girardi, B.H. Sweet, V.B. Slotnick, M.R. Hilleman.
Development of tumors in hamsters inoculated in the neonatal period with vacuolating virus SV-40.
Proc Soc Exp Biol Med, 109 (1962), pp. 649-660
[17.]
P.H. Black, W.P. Rowe, H.C. Turner, R.J. Huebner.
specific complement-fixing antigen present in SV40 tumor A transformed cells.
Proc Natl Acad Sci USA, 50 (1963), pp. 1148-1156
[18.]
K. Habel.
Specific complement-fixing antigens in polyoma tumors and transformed cells.
Virology, 25 (1965), pp. 55-61
[19.]
D. Burkitt.
A children's cancer dependent on climatic factors.
Nature, 194 (1962), pp. 232-234
[21.]
G. Henle, W. Henle, V. Diehl.
Relation of Burkitt's tumorassociated herpes-type virus to infectious mononucleosis.
Proc Natl Acad Sci USA, 59 (1968), pp. 94-101
[22.]
W. Henle, K. Hummeler, G. Henle.
Antibody coating and agglutination of virus particles separated from the EB3 line of Burkitt lymphoma cells.
J Bacteriol, 92 (1966), pp. 269-271
[23.]
L.J. Old, E.A. Boyse, H.F. Oettgen, E. De Harven, G. Geering, B. Williamson, et al.
Precipitating antibody in human serum to an antigen present in cultured Burkkit's lymphoma cells.
Proc Natl Acad Sci USA, 56 (1966), pp. 1699-1705
[24.]
R.E. Gallagher, R.C. Gallo.
Type C RNA tumor virus isolated from cultured human acute myelogenous leukemia cells.
Science, 187 (1975), pp. 350-353
[25.]
M.R. Das, A.B. Vaidya, S.M. Sirsat, D.H. Moore.
Polymerase and RNA studies on milk virions from women of the Parsi community.
J Natl Cancer Inst, 48 (1972), pp. 1191-1196
[26.]
R.P. Beasley, L.Y. Hwang, C.C. Lin, C.S. Chien.
Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan.
Lancet, 2 (1981), pp. 1129-1133
[27.]
Y. Hinuma, K. Nagata, M. Hanaoka, M. Nakai, T. Matsumoto, K.I. Kinoshita, et al.
Adult T-cell leukemia: antigen in an ATL cell line detection of antibodies to the antigen in human sera.
Proc Natl Acad Sci USA, 78 (1981), pp. 6476-6480
[28.]
R.G. Simonetti, M. Cottone, A. Craxi’, L. Pagliaro, M. Rapicetta, P. Chionne, et al.
Prevalence of antibodies to hepatitis C virus in hepatocellular carcinoma.
Lancet, 2 (1989), pp. 1338
[29.]
Y. Chang, E. Cesarman, M.S. Pessin, F. Lee, J. Culpepper, D.M. Knowles, et al.
Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.
Science, 266 (1994), pp. 1865-1869
[30.]
T.A. Doyen.
On the aetiology treatment of cancer.
Edinburgh Med J, 17 (1905), pp. 373-378
[31.]
S. Spicer, A.E. Wright.
Case of inoperable cancer of the fauces, the pharinx, the tongue and the cervical glands that has shown marked amelioration after treatment for ten weeks with a bacterial vaccine to neoformans.
J Laryngol, 21 (1906), pp. 265-269
[32.]
M. Wainwright.
Highly pleomorphic staphylococci as a cause of cancer.
Med Hypotheses, 54 (2000), pp. 91-94
[33.]
W.A. Felippe, G.L. Werneck, G. Santoro-Lopes.
Surgical site infection among women discharged with a drain in situ after breast cancer surgery.
World J Surg, 31 (2007), pp. 2293-2299
[34.]
T. Fukushima, Y. Kasai, K. Kato, K. Fujisawa, A. Uchida.
Intradural squamous cell carcinoma in the sacrum.
World J Surg Oncol, 7 (2009), pp. 16
[35.]
I. Brook.
Bacteria from solid tumours.
J Med Microbiol, 32 (1990), pp. 207-210
[36.]
D. Forman.
Helicobacter pylori infection: a novel risk factor in the etiology of gastric cancer.
J Natl Cancer Inst, 83 (1991), pp. 1702-1703
[37.]
A. Nomura, G.N. Stemmermann, P.H. Chyou, I. Kato, G.I. Pérez Pérez, M.J. Blaser.
Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii.
N Engl J Med, 325 (1991), pp. 1132-1136
[38.]
J. Parsonnet, D. Vandersteen, J. Goates, R.K. Sibley, J. Pritikin, Y. Chang.
Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas.
J Natl Cancer Inst, 83 (1991), pp. 640-643
[39.]
A.C. Wotherspoon, C. Ortiz-Hidalgo, M.R. Falzon, P.G. Isaacson.
Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma.
Lancet, 338 (1991), pp. 1175-1176
[40.]
O. Gal-Mor, B.B. Finlay.
Pathogenicity islands: a molecular toolbox for bacterial virulence.
Cell Microbiol, 8 (2006), pp. 1707-1719
[41.]
M. Juhas, J.R. van der Meer, M. Gaillard, R.M. Harding, D.W. Hood, D.W. Crook.
Genomic islands: tools of bacterial horizontal gene transfer and evolution.
FEMS Microbiol Rev, 33 (2009), pp. 376-393
[42.]
M.J. Oliveira, A.C. Costa, A.M. Costa, L. Henriques, G. Suriano, J.C. Atherton, et al.
Helicobacter pylori induces gastric epithelial cell invasion in a c-Met and type IV secretion system-dependent manner.
J Biol Chem, 281 (2006), pp. 34888-34896
[43.]
D.M. Pinto-Santini, N.R. Salama.
Cag3 is a novel essential component of the Helicobacter pylori Cag Type IV secretion system outer membrane subcomplex.
J Bacteriol, 191 (2009), pp. 7343-7352
[44.]
M. Juhas, D.W. Crook, D.W. Hood.
Type IV secretion systems: tools of bacterial horizontal gene transfer and virulence.
Cell Microbiol, 10 (2008), pp. 2377-2386
[45.]
A.J. Ferreri, M. Ponzoni, M. Guidoboni, C. De Conciliis, A.G. Resti, B. Mazzi, et al.
Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy.
J Clin Oncol, 23 (2005), pp. 5067-5073
[46.]
C. Schöllkopf, M. Melbye, L. Munksgaard, K.E. Smedby, K. Rostgaard, B. Glimelius, et al.
Borrelia infection and risk of non-Hodgkin lymphoma.
Blood, 111 (2008), pp. 5524-5529
[47.]
R.S. Klein, R.A. Recco, M.T. Catalano, S.C. Edberg, J.I. Casey, N.H. Steigbigel.
Association of Streptococcus bovis with carcinoma of the colon.
N Engl J Med, 297 (1977), pp. 800-802
[48.]
S.Y. Kim, S.I. Joo, J. Yi, E.C. Kim.
A Case of Streptococcus gallolyticus subsp. gallolyticus infective endocarditis with colon cancer: identification by 16S ribosomal DNA sequencing.
Korean J Lab Med, 30 (2010), pp. 160-165
[49.]
S. Wu, K.J. Rhee, E. Albesiano, S. Rabizadeh, X. Wu, H.R. Yen, et al.
A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses.
Nat Med, 15 (2009), pp. 1016-1022
[50.]
A.C. Costa, C. Figueiredo, E. Touati.
Pathogenesis of Helicobacter pylori infection.
Helicobacter, 14 (2009), pp. 15-20
[51.]
M. Hatakeyama.
Helicobacter pylori gastric carcinogenesis.
J Gastroenterol, 44 (2009), pp. 239-248
[52.]
H. Suzuki, E. Iwasaki, T. Hibi.
Helicobacter pylori and gastric cancer.
Gastric Cancer, 12 (2009), pp. 79-87
[53.]
A. Bottcher.
Zur Genese des perforierenden Magengeschwurs.
Dopater Medicinische Zeitschrift, 5 (1874), pp. 148
[54.]
B.J. Marshall, J.A. Armstrong, D.B. McGechie, R.J. Glancy.
Attempt to fulfil Koch's postulates for pyloric Campylobacter.
Med J Aust, 142 (1985), pp. 436-439
[55.]
L. Fuccio, R.M. Zagari, L.H. Eusebi, L. Laterza, V. Cennamo, L. Ceroni, et al.
Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?.
Ann Intern Med, 151 (2009), pp. 121-128
[56.]
C.Y. Wu, K.N. Kuo, M.S. Wu, Y.J. Chen, C.B. Wang, J.T. Lin.
Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease.
Gastroenterology, 137 (2009),
[57.]
A. Zullo, C. Hassan, A. Andriani, F. Cristofari, V. De Francesco, E. Ierardi, et al.
Eradication therapy for Helicobacter pylori in patients with gastric MALT lymphoma: a pooled data analysis.
Am J Gastroenterol, 104 (2009), pp. 1932-1937
[58.]
E.J. Beswick, G. Suárez, V.E.H. Reyes.
pylori host interactions that influence pathogenesis.
World J Gastroenterol, 12 (2006), pp. 5599-5605
[59.]
M.R. Amieva, E.M. El-Omar.
Host-bacterial interactions in Helicobacter pylori infection.
Gastroenterology, 134 (2008), pp. 306-323
[60.]
M. Romano, V. Ricci, R. Zarrilli.
Mechanisms of disease: Helicobacter pylori-related gastric carcinogenesis−implications for chemoprevention.
Nat Clin Pract Gastroenterol Hepatol, 3 (2006), pp. 622-632
[61.]
M. Sugimoto, Y. Yamaoka.
Virulence factor genotypes of Helicobacter pylori affect cure rates of eradication therapy.
Arch Immunol Ther Exp (Warsz), 57 (2009), pp. 45-56
[62.]
K.M. Bourzac, K. Guillemin.
Helicobacter pylori-host cell interactions mediated by type IV secretion.
Cell Microbiol, 7 (2005), pp. 911-919
[63.]
A. Snaith, E.M. El-Omar.
Helicobacter pylori: host genetics and disease outcomes.
Expert Rev Gastroenterol Hepatol, 2 (2008), pp. 577-585
[64.]
J.Q. Huang, G.F. Zheng, K. Sumanac, E.J. Irvine, R.H. Hunt.
Meta-analysis of the relationship between cagA seropositivity and gastric cancer.
Gastroenterology, 125 (2003), pp. 1636-1644
[65.]
A. Shibata, J. Parsonnet, T.A. Longacre, M.I. García, B. Puligandla, R.E. Davis, et al.
CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma.
Carcinogenesis, 23 (2002), pp. 419-424
[66.]
J. Parsonnet, G.D. Friedman, N. Orentreich, H. Vogelman.
Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.
Gut, 40 (1997), pp. 297-301
[67.]
E. Garza-González, F.J. Bosques-Padilla, G.I. Pérez-Pérez, J.P. Flores-Gutiérrez, R. Tijerina-Menchaca.
Association of gastric cancer. HLA-DQA1, and infection with Helicobacter pylori CagA+ and VacA+ in a Mexican population.
J Gastroenterol, 39 (2004), pp. 1138-1142
[68.]
D. Basso, C.F. Zambon, D.P. Letley, A. Stranges, A. Marchet, J.L. Rhead, et al.
Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms.
Gastroenterology, 135 (2008), pp. 91-99
[69.]
K. Baghaei, L. Shokrzadeh, F. Jafari, H. Dabiri, Y. Yamaoka, M. Bolfion, et al.
Determination of Helicobacter pylori virulence by analysis of the cag pathogenicity island isolated from Iranian patients.
Dig Liver Dis, 41 (2009), pp. 634-638
[70.]
M. Ali, A.A. Khan, S.K. Tiwari, N. Ahmed, L.V. Rao, C.M. Habibullah.
Association between cag-pathogenicity island in Helicobacter pylori isolates from peptic ulcer, gastric carcinoma, and non-ulcer dyspepsia subjects with histological changes.
World J Gastroenterol, 11 (2005), pp. 6815-6822
[71.]
S. Talarico, B.D. Gold, J. Fero, D.T. Thompson, J. Guarner, S. Czinn, et al.
Pediatric Helicobacter pylori isolates display distinct gene coding capacities and virulence gene marker profiles.
J Clin Microbiol, 47 (2009), pp. 1680-1688
[72.]
S. Takaishi, S. Tu, Z.A. Dubeykovskaya, M.T. Whary, S. Muthupalani, B.H. Rickman, et al.
Gastrin is an essential cofactor for Helicobacter-associated gastric corpus carcinogenesis in C57BL/6 mice.
Am J Pathol, 175 (2009), pp. 365-375
[73.]
R.M. Quirós, C.L. Bui.
Multidisciplinary approach to esophageal and gastric cancer.
Surg Clin North Am, 89 (2009), pp. 79-96
[74.]
D.Y. Graham, M. Asaka.
Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod.
J Gastroenterol, 45 (2010), pp. 1-8
[75.]
M. Ito, S. Takata, M. Tatsugami, Y. Wada, S. Imagawa, Y. Matsumoto, et al.
Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review.
J Gastroenterol, 44 (2009), pp. 365-371
[76.]
G. Suárez, V.E. Reyes, E.J. Beswick.
Immune response to H. pylori.
World J Gastroenterol, 12 (2006), pp. 5593-5598
[77.]
G. Del Giudice, P. Malfertheiner, R. Rappuoli.
Development of vaccines against Helicobacter pylori.
Expert Rev Vaccines, 8 (2009), pp. 1037-1049
[78.]
M. Pandey, M. Shukla.
Helicobacter species are associated with possible increase in risk of hepatobiliary tract cancers.
Surg Oncol, 18 (2009), pp. 51-56
[79.]
C. De Martel, M. Plummer, J. Parsonnet, L.J. Van Doorn, S. Franceschi.
Helicobacter species in cancers of the gallbladder and extrahepatic biliary tract.
Br J Cancer, 100 (2009), pp. 194-199
[80.]
S.Y. Xuan, Y.N. Xin, A.J. Chen, Q.J. Dong, X. Qiang, N. Li, et al.
Association between the presence of H. pylori in the liver and hepatocellular carcinoma: a meta-analysis.
World J Gastroenterol, 14 (2008), pp. 307-312
[81.]
W. Abu Al-Soud, U. Stenram, A. Ljungh, K.G. Tranberg, H.O. Nilsson, T. Wadström.
DNA of Helicobacter spp. and common gut bacteria in primary liver carcinoma.
Dig Liver Dis, 40 (2008), pp. 126-131
[82.]
P. Avenaud, A. Marais, L. Monteiro, B. Le Bail, P. Bioulac Sage, C. Balabaud, et al.
Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma.
Cancer, 89 (2000), pp. 1431-1439
[83.]
R. Pellicano, V. Mazzaferro, W.F. Grigioni, M.A. Cutufia, S. Fagoonee, L. Silengo, et al.
Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma.
World J Gastroenterol, 10 (2004), pp. 598-601
[84.]
B.A. Diwan, M. Sipowicz, D. Logsdon, P. Gorelick, M.R. Anver, K.S. Kasprzak, et al.
Marked liver tumorigenesis by Helicobacter hepaticus requires perinatal exposure.
Environ Health Perspect, 116 (2008), pp. 1352-1356
[85.]
K.A. Canella, B.A. Diwan, P.L. Gorelick, P.J. Donovan, M.A. Sipowicz, K.S. Kasprzak, et al.
Liver tumorigenesis by Helicobacter hepaticus: considerations of mechanism.
In Vivo, 10 (1996), pp. 285-292
[86.]
T. Hamada, K. Yokota, K. Ayada, K. Hirai, T. Kamada, K. Haruma, et al.
Detection of Helicobacter hepaticus in human bile samples of patients with biliary disease.
Helicobacter, 14 (2009), pp. 545-551
[87.]
B. Lindkvist, D. Johansen, A. Borgström, J. Manjer.
A prospective study of Helicobacter pylori in relation to the risk for pancreatic cancer.
BMC Cancer, 8 (2008), pp. 321
[88.]
N. Masoud, K. Manouchehr, D. Najmeh, H. Monireh.
Lack of association between Helicobacter pylori and laryngeal carcinoma.
Asian Pac J Cancer Prev, 9 (2008), pp. 81-82
[89.]
J. Rezaii, H. Tavakoli, K. Esfandiari, H. Ashegh, M. Hasibi, G. Ghanei, et al.
Association between Helicobacter pylori infection and laryngo-hypopharyngeal carcinoma: a case-control study and review of the literature.
Head Neck, 30 (2008), pp. 1624-1627
[90.]
A.N. Burnett-Hartman, P.A. Newcomb, J.D. Potter.
Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis JC virus, and human papillomavirus.
Cancer Epidemiol Biomarkers Prev, 17 (2008), pp. 2970-2979
[91.]
Y.S. Zhao, F. Wang, D. Chang, B. Han, D.Y. You.
Meta-analysis of different test indicators: Helicobacter pylori infection and the risk of colorectal cancer.
Int J Colorectal Dis, 23 (2008), pp. 875-882
[92.]
A. Boleij, R.M. Schaeps, H. Tjalsma.
Association between Streptococcus bovis and colon cancer.
J Clin Microbiol, 47 (2009), pp. 516
[93.]
C.M. Nagamine, J.J. Sohn, B.H. Rickman, A.B. Rogers, J.G. Fox, D.B. Schauer.
Helicobacter hepaticus infection promotes colon tumorigenesis in the BALB/c-Rag2(−/−) Apc(Min/+) mouse.
Infect Immun, 76 (2008), pp. 2758-2766
[94.]
R. Pellicano, A. Ménard, M. Rizzetto, F. Mégraud.
Helicobacter species and liver diseases: association or causation?.
Lancet Infect Dis, 8 (2008), pp. 254-260
[95.]
D. Steinberg, C.Z. Naggar.
Streptococcus bovis endocarditis with carcinoma of the colon.
N Engl J Med, 297 (1977), pp. 1354-1355
[96.]
J. Corredoira, M.P. Alonso, A. Coira, J. Varela.
Association between Streptococcus infantarius (Formerly S. bovis II/1) Bacteremia and Noncolonic Cancer.
J Clin Microbiol, 46 (2008), pp. 1570
[97.]
A.S. Abdulamir, R.R. Hafidh, L.K. Mahdi, T. Al-jeboori, F. Abubaker.
Investigation into the controversial association of Streptococcus gallolyticus with colorectal cancer and adenoma.
BMC Cancer, 9 (2009), pp. 403
[98.]
A. Ferrari, I. Botrugno, E. Bombelli, T. Dominioni, E. Cavazzi, P. Dionigi.
Colonoscopy is mandatory after Streptococcus bovis endocarditis: a lesson still not learned.
World J Surg Oncol, 6 (2008), pp. 49
[99.]
D. Schneider, L. Liaw, C. Daniel, A.N. Athanasopoulos, M. Herrmann, K.T. Preissner, et al.
Inhibition of breast cancer cell adhesion and bone metastasis by the extracellular adherence protein of Staphylococcus aureus.
Biochem Biophys Res Commun, 357 (2007), pp. 282-288
[100.]
A.J. Edey, P.G. Bentley, J.P. Garrett, R.D. Liebmann.
Ductal breast carcinoma presenting with methicillin-resistant Staphylococcus aureus mastitis.
Breast J, 11 (2005), pp. 491-492
[101.]
Z. Ma, L. Liu, F. Zhang, M. Yu, K. Wang, J. Luo, et al.
Human papillomavirus type 16 exists in bacteria isolated from cervical cancer biopsies.
J Int Med Res, 37 (2009), pp. 1065-1074
[102.]
M. Gugger, J.C. Reubi.
Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast.
Am J Pathol, 155 (1999), pp. 2067-2076
[103.]
K. Yonemori, M. Sumi, N. Fujimoto, Y. Ito, A. Imai, Y. Kagami, et al.
Progastrin-releasing peptide as a factor predicting the incidence of brain metastasis in patients with small cell lung carcinoma with limited disease receiving prophylactic cranial irradiation.
Cancer, 104 (2005), pp. 811-816
[104.]
C.C. Prelipcean, C. Mihai, P. Gogalniceanu, D. Mitrica, V.L. Drug, C. Stanciu.
Extragastric manifestations of Helicobacter pylori infection.
Rev Med Chir Soc Med Nat Iasi, 111 (2007), pp. 575-583
[105.]
T.C. Theoharides.
Mast cells pancreatic cancer.
N Engl J Med, 358 (2008), pp. 1860-1861
[106.]
J. Kountouras, C. Zavos, M.D. Diamantidis, G. Deretzi, N. Grigoriadis, G. Tsapournas, et al.
A concept of Helicobacter pylori and stress-secreted mast cells’ potential involvement in brain metastases.
J Neuroimmunol, 209 (2009), pp. 121-122
[107.]
M. Leverkus, A.M. Finner, A. Pokrywka, I. Franke, H. Gollnick.
Metastatic squamous cell carcinoma of the ankle in long-standing untreated acrodermatitis chronica atrophicans.
Dermatology, 217 (2008), pp. 215-218
[108.]
V. Verma, D. Shen, P.C. Sieving, C.C. Chan.
The role of infectious agents in the etiology of ocular adnexal neoplasia.
Surv Ophthalmol, 53 (2008), pp. 312-331
[109.]
C.C. Chan, D. Shen, M. Mochizuki, J.A. Gonzales, H.K. Yuen, Y. Guex-Crosier, et al.
Detection of Helicobacter pylori and Chlamydia pneumoniae genes in primary orbital lymphoma.
Trans Am Ophthalmol Soc, 104 (2006), pp. 62-70
[110.]
S.B. Lee, J.W. Yang, C.S. Kim.
The association between conjunctival MALT lymphoma and Helicobacter pylori.
Br J Ophthalmol, 92 (2008), pp. 534-536
[111.]
E. Chanudet, Y. Zhou, C.M. Bacon, A.C. Wotherspoon, H.K. Müller-Hermelink, P. Adam, et al.
Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions.
J Pathol, 209 (2006), pp. 344-351
[112.]
A. Aigelsreiter, E. Leitner, A.J. Deutsch, H.H. Kessler, E. Stelzl, C. Beham-Schmid, et al.
Chlamydia psittaci in MALT lymphomas of ocular adnexals: the Austrian experience.
Leuk Res, 32 (2008), pp. 1292-1294
[113.]
R.L. Vargas, E. Fallone, R.E. Felgar, J.W. Friedberg, A.A. Arbini, A.A. Andersen, et al.
Is there an association between ocular adnexal lymphoma and infection with Chlamydia psittaci? The University of Rochester experience.
Leuk Res, 30 (2006), pp. 547-551
[114.]
Y.C. Liu, J.H. Ohyashiki, Y. Ito, K. Iwaya, H. Serizawa, K. Mukai, et al.
Chlamydia psittaci in ocular adnexal lymphoma: Japanese experience.
Leuk Res, 30 (2006), pp. 1587-1589
[115.]
K.D. Quint, M.N. de Koning, D.T. Geraets, W.G. Quint, E.C. Pirog.
Comprehensive analysis of human papillomavirus and Chlamydia trachomatis in in-situ and invasive cervical adenocarcinoma.
Gynecol Oncol, 114 (2009), pp. 390-394
[116.]
J.P. Carvalho, F.M. Carvalho.
Is Chlamydia-infected tubal fimbria the origin of ovarian cancer?.
Med Hypotheses, 71 (2008), pp. 690-693
[117.]
Y. Xu, N. Stange-Thomann, G. Weber, R. Bo, S. Dodge, R.G. David, et al.
Pathogen discovery from human tissue by sequence-based computational subtraction.
Genomics, 81 (2003), pp. 329-335
[118.]
H. Feng, J.L. Taylor, P.V. Benos, R. Newton, K. Waddell, S.B. Lucas, et al.
Human transcriptome subtraction by using short sequence tags to search for tumor viruses in conjunctival carcinoma.
J Virol, 81 (2007), pp. 11332-11340
[119.]
C.G. Duncan, R.J. Leary, J.C. Lin, J. Cummins, C. Di, C.F. Schaefer, et al.
Identification of microbial DNA in human cancer.
BMC Med Genomics, 8 (2009), pp. 2-22
[120.]
R.D. Sleator, C. Shortall, C. Hill.
Metagenomics.
Lett Appl Microbiol, 47 (2008), pp. 361-366
[121.]
W.J. Ansorge.
Next-generation DNA sequencing techniques.
N Biotechnol, 25 (2009), pp. 195-203
[122.]
M. Avila, D.M. Ojcius, O. Yilmaz.
The oral microbiota: living with a permanent guest.
DNA Cell Biol, 28 (2009), pp. 405-411
[123.]
M. Ventura, F. Turroni, C. Canchaya, E. Vaughan, P.W. O’Toole, D. Van Sinderen.
Microbial diversity in the human intestine and novel insights from metagenomics.
Front Biosci, 14 (2009), pp. 3214-3221
[124.]
G. Muyzer, E.C. De Waal, A.G. Uitterlinden.
Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reactionamplified genes coding for 16S rRNA.
Appl Environ Microbiol, 59 (1993), pp. 695-700
[125.]
F. Schwieger, C.C. Tebbe.
A new approach to utilize PCR-single-strand-conformation polymorphism for 16S rRNA gene-based microbial community analysis.
Appl Environ Microbiol, 64 (1998), pp. 4870-4876
[126.]
A. Peix, R. Rivas, E. Velázquez, P.F. Mateos, E. Martínez-Molina, A. Muñoz-Herrera, et al.
Application of horizontal staircase electrophoresis in agarose minigels to the random intergenic spacer analysis of clinical samples.
Electrophoresis, 26 (2005), pp. 4402-4410
[127.]
P.D. Scanlan, F. Shanahan, J.R. Marchesi.
Culture-independent analysis of desulfovibrios in the human distal colon of healthy, colorectal cancer and polypectomized individuals.
FEMS Microbiol Ecol, 69 (2009), pp. 213-221
[128.]
J.W. Lampe.
The Human Microbiome Project: Getting to the guts of the matter in cancer epidemiology.
Cancer Epidemiol Biomarkers Prev, 17 (2008), pp. 2523-2532
[129.]
L. Yang, X. Lu, C.W. Nossa, F. Francois, R.M. Peek, Z. Pei.
Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome.
Gastroenterology, 137 (2009), pp. 588-597
[130.]
M.J. Van Vliet, W.J. Tissing, C.A. Dun, N.E. Meessen, W.A. Kamps, E.S. De Bont, et al.
Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut.
Clin Infect Dis, 49 (2009), pp. 262-270
[131.]
H.E. Jakobsson, C. Jernberg, A.F. Andersson, M. Sjölund-Karlsson, J.K. Jansson, L. Engstrand.
Short-term antibiotic treatment has differing long-term impacts on the human throat gut microbiome.
PLoS ONE, 5 (2010), pp. e9836
[132.]
M.J. Van Vliet, H.J. Harmsen, E.S. De Bont, W.J. Tissing.
The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis.
PLoS Pathog, 6 (2010), pp. e1000879
Copyright © 2011. Asociación Española de Cirujanos
